MacroGenics Announces Date of Fourth Quarter 2022 Financial

MacroGenics Announces Date of Fourth Quarter 2022 Financial

ROCKVILLE, MD, March 07, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and......

Broadwind Reports Fourth Quarter and Full-Year 2022

Broadwind Reports Fourth Quarter and Full-Year 2022

CICERO, Ill., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Broadwind (NASDAQ: BWEN), a diversified precision manufacturer of specialized components and solutions......

Arbutus to Report Fourth Quarter and Year End 2022

Arbutus to Report Fourth Quarter and Year End 2022

WARMINSTER, Pa., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging......

Retail Opportunity Investments Corp. Reports 2022 Results

Retail Opportunity Investments Corp. Reports 2022 Results

SAN DIEGO, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Retail Opportunity Investments Corp. (NASDAQ:ROIC) announced today financial and operating results for the......

menu
menu